Darby Sedighan

Corp Affairs, Amgen

[Amgen Oncology @AmgenOncology]

.@Amgen continues to pursue potential therapies utilizing BiTE® technology to help #bloodcancer patients like Annmarie. #ASH19

[Amgen 🧪🔬🧬 @Amgen]

Lots of great conversations taking place at today's @AtlanticLive's #PeoplevCancer event in NYC. You never know who you'll see there. Tune in here: https://t.co/Q9Gm4eEzjw

[Amgen Oncology @AmgenOncology]

Today we'll be live tweeting from @AtlanticLIVE’s #PeopleVCancer in NYC. Follow along as we share stories throughout the day! Join the livestream here: https://t.co/t4U2qDSW2q

[Amgen Oncology @AmgenOncology]

#Riseandshine: The @Amgen sponsored panel on the role of precision medicine in cancer treatment begins at 11:30am ET/8:30am PT. Cancer treatment is no longer a one-size fits all approach. Panel live-stream available here: https://t.co/iLLnyOWL8A #PeopleVCancer

[Amgen 🧪🔬🧬 @Amgen]

With the rapid growth of precision medicine, is #biomarkertesting the key to personalized cancer treatment? @AmgenOncology is exploring how to transform outcomes for patients. #PeopleVCancer

[AtlanticLIVE @AtlanticLIVE]

There are only two days until #PeopleVCancer underwritten by @bmsnews, @aflac, @AACR, + @Amgen, + hosted in collaboration with @SurvivorNetTeam, but you can still RSVP to attend in NYC. Learn more and register today: https://t.co/aY8RzTH4rl

[Amgen Oncology @AmgenOncology]

.@Amgen will be at @AtlanticLive's #PeopleVCancer on Tuesday, 11/12 highlighting the importance of personalized treatment for #cancer patients. Join experts I-Fen Chang, @HosseinBorghaei, @LindaSueHouse, and Jordan Laser.

[Darby Sedighan @darbystern]

It’s a wrap! #ESMO2019

[Amgen 🧪🔬🧬 @Amgen]

#Amgen announces new clinical data from ongoing Phase 1 study evaluating AMG 510 in patients with previously treated KRAS G12C-mutated solid tumors. These data are being presented during #WCLC19 oral presentation hosted by International Association for the Study of Lung Cancer.

[Darby Sedighan @darbystern]

Excited to be at #WCLC19 @AmgenOncology

[Amgen Oncology @AmgenOncology]

Find out what drives @Amgen’s approach in the field of #oncology, and why we believe it’s important to stand side-by-side with patients and their families. #KRASG12C #WCLC19

[Amgen Oncology @AmgenOncology]

Today is the first day of #WCLC19 and we’re excited to connect with HCPs, patients, researchers, and caregivers to help advance #cancer research and improve patients’ lives. #KRASG12C #Booth102

[Amgen Oncology @AmgenOncology]

We’re pioneering groundbreaking advances in #lungcancer treatment and look forward to meeting other industry leaders at #WCLC19 tomorrow in Barcelona, Spain. #KRASG12C #Booth102

[Amgen Oncology @AmgenOncology]

.@DCPatient, @LazarexaErin, Deborah Schrag, MD, MPH, and Karim Iskander PHD were on stage to discuss the latest in #clinicaltrials. The #ChasingCancer livestream continues here: https://t.co/HF81SzZOMX

[Darby Sedighan @darbystern]

Director of Corporate Affairs – Oncology Pipeline | Amgen https://t.co/YxuO87eNPA

[Darby Sedighan @darbystern]

A little fun while at #EHA2019 with the team

[Darby Sedighan @darbystern]

@szusmani @PearlJam @TomBmt133 @kaufman_MMdoc Sounds fun!

[Darby Sedighan @darbystern]

Just enjoying some coffee and reading this morning at ASCO

[AtlanticLIVE @AtlanticLIVE]

.@Amgen's Richard Markus breaks down what creating a biosimilar involves, from acquiring the reference product to demonstrating comparable efficacy at #AtlanticNewFrontier